PIK3CA and mood disorder: However, the physiopathology of mood disorders associated with pan-PI3K inhibitors has not been well characterized, and it remains unclear whether the higher incidence of neuropsychiatric effects observed with buparlisib compared to isoform-selective PI3K inhibitors is due to its elevated CNS penetration or to other pharmacokinetic differences.